MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Delayed Börse Stuttgart 06:46:01 23/05/2024 pm IST | ||
| 0.97 EUR | +1.04% |
|
| Current month | -6.80% | ||
| 1 month | -17.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 23/24/23 | 0.97 | +1.04% |
| 22/24/22 | 0.96 | -13.51% |
| 21/24/21 | 1.11 | +2.78% |
| 20/24/20 | 1.08 | -4.42% |
| 17/24/17 | 1.13 | +4.63% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 06:46 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MB60HE |
| ISIN | DE000MB60HE9 |
| Date issued | 03/05/2023 |
| Strike | 39.22 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.41 € |
|---|---|
| Lowest since issue | 0.34 € |
| Spread | 0.01 € |
| Spread % | 1.02% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.16
EUR
Average target price
52.24
EUR
Spread / Average Target
+6.27%
- Stock Market
- Certificates
- Certificat
